Calidi Biotherapeutics, Inc.
Develops stem cell platforms to deliver oncolytic viruses for cancer therapy.
CLDI | US
Overview
Corporate Details
- ISIN(s):
- US3207031010 (+1 more)
- LEI:
- Country:
- United States of America
- Address:
- 4475 EXECUTIVE DRIVE, 92121 SAN DIEGO
- Website:
- https://www.calidibio.com/
- Sector:
- Manufacturing
Description
Calidi Biotherapeutics, Inc. is a clinical-stage immuno-oncology company that develops targeted therapies for cancer. The company's proprietary technology platforms utilize allogeneic stem cells to deliver and shield oncolytic virus payloads from the patient's immune system. This approach is designed to enable the potentiation of the viral therapy, activating the immune system to destroy solid tumors and metastatic disease. Calidi's pipeline includes both systemic and localized treatments being investigated for various cancers, including a first-in-class, stem-cell-loaded viral therapy for soft tissue sarcoma which has received FDA Fast Track Designation.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Calidi Biotherapeutics, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Calidi Biotherapeutics, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Calidi Biotherapeutics, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
